Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 251: Why is glyceryl trinitrate (GTN) administered sublingually?

A. To avoid first-pass metabolism (Correct Answer)
B. For rapid onset of action
C. To prevent gastric irritation
D. To minimize side effects

Explanation: Explanation:1. Why Option A is Correct:Glyceryl Trinitrate (GTN) undergoes extensive high first-pass metabolism in the liver (nearly 90-100% extraction ratio) [1, 2]. If taken orally, the drug is absorbed from the GI tract into the portal circulation and metabolized by hepatic enzymes before reaching the systemic circulation, rendering it ineffective [1, 2]. The sublingual route allows the drug to be absorbed directly through the oral mucosa into the systemic venous circulation (via the superior vena cava), bypassing the liver and ensuring high bioavailability [1].2. Why Other Options are Incorrect:Option B: While sublingual administration does provide a rapid onset of action (1–3 minutes) [2], the primary pharmacological reason for choosing this route over the oral route is the avoidance of metabolic degradation [1]. Rapid onset is a clinical benefit, but avoiding first-pass metabolism is the pharmacokinetic necessity.Option C: GTN is not inherently a gastric irritant; the route is chosen for pharmacokinetic stability, not to protect the stomach lining.Option D: Sublingual administration actually increases the risk of systemic side effects (like throbbing headache and hypotension) because it achieves higher plasma concentrations more quickly than oral administration.3. NEET-PG High-Yield Pearls:Drug of Choice: Sublingual GTN is the drug of choice for acute anginal attacks.Storage: GTN is volatile and light-sensitive; it must be stored in tightly closed, dark glass containers.Mechanism: It acts by releasing Nitric Oxide (NO), which increases cGMP, leading to dephosphorylation of myosin light chains and resulting in venodilation (reducing preload).Other drugs with high first-pass metabolism: Propranolol, Lidocaine, Salbutamol, and Morphine.

Question 252: An intravenous bolus dose of thiopentone leads to loss of consciousness within 10-15 seconds. The patient regains consciousness in just a few minutes. This is because it is:

A. Renally excreted
B. Exhaled rapidly
C. Rapidly metabolized by hepatic enzymes
D. Redistributed from brain to other body tissues (Correct Answer)

Explanation: **Explanation:** The rapid onset and short duration of action of thiopentone are classic examples of **redistribution**, a pharmacokinetic phenomenon seen with highly lipid-soluble drugs. **1. Why Option D is Correct:** Thiopentone is highly lipophilic. Upon IV bolus administration, it rapidly crosses the blood-brain barrier and reaches peak concentrations in the brain (a highly perfused organ) within seconds, causing immediate anesthesia. However, as the plasma concentration falls, the drug begins to move down its concentration gradient, shifting from the brain back into the blood and then into less perfused tissues like **skeletal muscle** and eventually **adipose tissue**. This "redistribution" lowers the concentration in the brain below the therapeutic threshold, leading to a rapid recovery of consciousness (usually within 5–10 minutes), long before the drug is actually metabolized or excreted. **2. Why Other Options are Incorrect:** * **A & C:** While thiopentone is eventually metabolized by the liver and excreted by the kidneys, these processes are relatively slow. Hepatic metabolism accounts for the ultimate elimination of the drug but is not responsible for the initial, rapid termination of its anesthetic effect. * **B:** Thiopentone is a barbiturate, not an inhalational anesthetic. It is not eliminated via the lungs. **3. High-Yield Clinical Pearls for NEET-PG:** * **Context-Sensitive Half-life:** While a single dose has a short duration due to redistribution, **repeated doses or continuous infusion** lead to saturation of muscle and fat stores. This causes the drug to accumulate, significantly prolonging the recovery time. * **Thiopentone vs. Propofol:** Propofol also undergoes redistribution but has a faster metabolic clearance, making it more suitable for continuous infusion than thiopentone. * **Storage:** Thiopentone is primarily sequestered in **adipose tissue** for long-term storage after the initial redistribution to muscle.

Question 253: Which of the following are drug transport mechanisms?

A. Active transport (Correct Answer)
B. Passive transport
C. Lipid solubility
D. Bioavailability

Explanation: **Explanation:** Drug transport refers to the movement of drug molecules across biological membranes. The primary mechanisms of drug transport include **Passive Diffusion**, **Facilitated Diffusion**, **Active Transport**, and **Pinocytosis/Endocytosis**. **1. Why Active Transport is Correct:** Active transport is a specialized mechanism where drugs move **against a concentration gradient** (from low to high concentration). This process requires **energy (ATP)** and specific **carrier proteins**. It is characterized by selectivity, saturability (Vmax), and the potential for competitive inhibition. Examples include the transport of levodopa across the blood-brain barrier and the secretion of penicillin in renal tubules. **2. Why the other options are incorrect:** * **Passive transport:** While passive *diffusion* is a transport mechanism, "Passive transport" as a standalone term in this specific MCQ context is often considered a general category rather than a specific mechanism like Active Transport. However, in many textbooks, it is a valid mechanism. In this specific question format, Active Transport is the most definitive "mechanism" involving cellular machinery. * **Lipid solubility:** This is a **physicochemical property** of a drug, not a transport mechanism. High lipid solubility facilitates passive diffusion across the phospholipid bilayer, but it is a characteristic of the molecule itself. * **Bioavailability:** This is a **pharmacokinetic parameter** defined as the fraction of an administered dose of unchanged drug that reaches the systemic circulation. It is a result of absorption and first-pass metabolism, not a transport mechanism. **NEET-PG High-Yield Pearls:** * **Most common mechanism:** Passive diffusion (follows Fick’s Law; non-saturable). * **P-glycoprotein (P-gp):** An efflux transporter (active transport) that pumps drugs out of cells, often contributing to multi-drug resistance in cancer. * **Ion Trapping:** Acidic drugs (e.g., Aspirin) are better absorbed in acidic environments (stomach) because they remain unionized and lipid-soluble.

Question 254: What is the most general term for the process by which the amount of active drug in the body is reduced after absorption into the systemic circulation?

A. Excretion
B. Elimination (Correct Answer)
C. First pass metabolism
D. Distribution

Explanation: **Explanation:** **Elimination** is the correct answer because it is the broad, overarching term that encompasses all processes leading to the termination of drug action and its removal from the body. Once a drug enters the systemic circulation, its concentration is reduced through two primary mechanisms: **Metabolism** (biotransformation, usually by the liver) and **Excretion** (physical removal, usually by the kidneys). Therefore, Elimination = Metabolism + Excretion. **Analysis of Incorrect Options:** * **Excretion (A):** This is a subset of elimination. It refers specifically to the physical removal of the drug or its metabolites from the body (via urine, bile, sweat, etc.). It does not account for the chemical inactivation of the drug (metabolism). * **First-pass metabolism (C):** This occurs *before* the drug reaches systemic circulation. It refers to the metabolism of a drug in the gut wall or liver during its first passage after oral absorption, which reduces bioavailability. * **Distribution (D):** This is the reversible transfer of a drug from the systemic circulation to the tissues. While it reduces the concentration of the drug in the plasma, it does not reduce the total "amount of active drug in the body." **High-Yield NEET-PG Pearls:** * **Clearance (CL):** The theoretical volume of plasma from which the drug is completely removed per unit of time. It is the most important parameter for calculating the **maintenance dose**. * **Zero-order Kinetics:** A constant *amount* of drug is eliminated per unit time (e.g., Alcohol, Phenytoin, Salicylates). * **First-order Kinetics:** A constant *fraction* of drug is eliminated per unit time (most drugs follow this). * **Steady State:** Reached after approximately **4 to 5 half-lives**.

Question 255: What characterizes an agonist in terms of receptor binding and effect?

A. Has affinity for the receptor and exhibits intrinsic activity (Correct Answer)
B. Has affinity for the receptor but lacks intrinsic activity
C. Has affinity for the receptor and exhibits negative intrinsic activity
D. None of the above

Explanation: To understand the action of drugs on receptors, two fundamental concepts are essential: **Affinity** (the ability of a drug to bind to a receptor) and **Intrinsic Activity/Efficacy** (the ability of a drug to activate the receptor and produce a biological response). ### Explanation of the Correct Answer **Option A** is correct because an **agonist** is a molecule that mimics the action of an endogenous ligand. It possesses both **affinity** (it can "fit" into the receptor lock) and **intrinsic activity** (it can "turn" the key to trigger a cellular response). By definition, a full agonist has an intrinsic activity of **1**. ### Why Other Options are Incorrect * **Option B:** This describes an **Antagonist**. Antagonists have affinity (they bind to the receptor) but zero intrinsic activity (they do not trigger a response). They work solely by blocking agonists from binding. * **Option C:** This describes an **Inverse Agonist**. These drugs have affinity but exhibit **negative intrinsic activity** (less than zero), meaning they stabilize the receptor in its inactive state and decrease the baseline (constitutive) activity of the receptor system. ### NEET-PG High-Yield Pearls * **Partial Agonist:** Has affinity but **submaximal intrinsic activity** (between 0 and 1). Even at 100% receptor occupancy, it cannot produce a maximal response. * **Competitive Antagonist:** Shifts the dose-response curve to the **right** (increases $ED_{50}$), but the maximal response ($E_{max}$) remains unchanged because it can be overcome by increasing agonist concentration. * **Non-competitive Antagonist:** Reduces the **maximal response** ($E_{max}$) because it binds irreversibly or at an allosteric site, effectively removing functional receptors from the system.

Question 256: Which of the following is not an inducer of CYP3A4?

A. Barbiturates
B. Glucocorticoids
C. Phenytoin
D. Erythromycin (Correct Answer)

Explanation: The Cytochrome P450 (CYP) enzyme system is the primary pathway for hepatic drug metabolism. CYP3A4 is the most abundant isoform, responsible for metabolizing nearly 50% of all clinically used drugs. Why Erythromycin is the correct answer: Erythromycin is a potent inhibitor of CYP3A4, not an inducer. It binds covalently to the iron atom of the heme group in the enzyme, forming an inactive complex [1]. This inhibition leads to decreased metabolism and increased toxicity of co-administered substrates like Theophylline, Warfarin, and Statins [2]. Why the other options are incorrect: * A. Barbiturates (e.g., Phenobarbital): These are classic, broad-spectrum microsomal enzyme inducers [1]. They increase the synthesis of CYP enzymes (3A4, 2C9) by activating the Constitutive Androstane Receptor (CAR). * B. Glucocorticoids: Drugs like Dexamethasone act as inducers of CYP3A4 by binding to the Pregnane X Receptor (PXR), which upregulates enzyme transcription [2]. * C. Phenytoin: A potent inducer of multiple CYP isoforms, including 3A4 [1]. This often leads to significant drug-drug interactions, such as reducing the efficacy of oral contraceptives. High-Yield Clinical Pearls for NEET-PG: * Mnemonic for Inducers (GPRS Cell Phone): Griseofulvin, Phenytoin, Rifampicin, Smoking, Carbamazepine, Phenobarbital. (Note: St. John’s Wort is also a potent inducer [2]). * Mnemonic for Inhibitors (VITAMIN K): Valproate, Isoniazid, Terefenadine (historical), Amiodarone, Macrolides (except Azithromycin), Indinavir, Non-DHP CCBs (Verapamil/Diltiazem), Ketoconazole (and Cimetidine/Grapefruit juice [2]). * Key Distinction: Azithromycin is the only common macrolide that does not significantly inhibit CYP3A4.

Question 257: Streptomycin single dose is more effective than multiple small doses because it is -

A. Concentration dependent lytic effect (Correct Answer)
B. Longer half-life
C. Not dependent on renal clearance
D. Tubular secretion and reabsorption is more

Explanation: **Explanation:**The correct answer is **A. Concentration dependent lytic effect.**Streptomycin belongs to the **Aminoglycoside** class of antibiotics. These drugs exhibit **Concentration-Dependent Killing (CDK)**, meaning their bactericidal efficacy increases as the peak concentration ($C_{max}$) exceeds the Minimum Inhibitory Concentration (MIC) of the pathogen [1]. A single large dose achieves a higher peak concentration compared to divided smaller doses, leading to more rapid and extensive bacterial lysis.Furthermore, Aminoglycosides possess a significant **Post-Antibiotic Effect (PAE)**—a period of continued bacterial growth suppression even after the drug concentration falls below the MIC. High peak concentrations achieved by single daily dosing (SDD) prolong this PAE, allowing for effective once-daily administration despite a relatively short plasma half-life [1].**Analysis of Incorrect Options:** * **B. Longer half-life:** Streptomycin actually has a relatively short plasma half-life (approx. 2–3 hours). Its prolonged effect is due to PAE, not its metabolic half-life. * **C. Not dependent on renal clearance:** This is incorrect. Aminoglycosides are excreted almost entirely unchanged via glomerular filtration; dosage must be adjusted in renal failure [2]. * **D. Tubular secretion and reabsorption:** Aminoglycosides are primarily filtered by the glomeruli. While a small amount is reabsorbed by proximal tubule cells (leading to nephrotoxicity), this does not explain why a single dose is more effective.**High-Yield Clinical Pearls for NEET-PG:** * **Dosing Strategy:** Single daily dosing (Pulse dosing) of Aminoglycosides reduces the risk of **nephrotoxicity** and **ototoxicity** because the uptake mechanisms in the kidney and inner ear are saturable; a single peak results in less total tissue accumulation than multiple smaller peaks [3]. * **Resistance:** Streptomycin resistance most commonly occurs due to a mutation in the **30S ribosomal protein (S12)** or the **16S rRNA**. * **Drug of Choice:** Streptomycin is a first-line drug for **Plague** and **Tularemia**, and a second-line drug for **Tuberculosis**.

Question 258: Antacids interfere with the absorption of which of the following drugs?

A. Ketoconazole
B. Azithromycin (Correct Answer)
C. Oxytetracycline
D. Ofloxacin

Explanation: **Explanation:** The absorption of various drugs is significantly influenced by gastric pH and the presence of multivalent cations (like $Al^{3+}$, $Mg^{2+}$, and $Ca^{2+}$) found in antacids. **Why Azithromycin is the Correct Answer:** Azithromycin absorption is unique among macrolides in that its **bioavailability is significantly decreased (by approximately 43%)** when administered concurrently with aluminum and magnesium-containing antacids. While the exact mechanism is a reduction in the rate of absorption ($C_{max}$), the clinical impact is substantial enough that patients are advised to take azithromycin at least 1 hour before or 2 hours after antacid consumption. **Analysis of Incorrect Options:** * **Oxytetracycline & Ofloxacin:** These drugs interact with antacids via **chelation**. They form insoluble complexes with multivalent cations ($Ca^{2+}, Mg^{2+}, Al^{3+}$), which prevents their absorption. While antacids *do* interfere with them, in the context of standard pharmacological teaching and specific exam patterns (like NEET-PG), Azithromycin is often highlighted due to its specific pharmacokinetic profile regarding peak serum concentrations. * **Ketoconazole:** This is an azole antifungal that requires an **acidic environment** for dissolution and absorption. Antacids increase gastric pH, thereby reducing its absorption. **NEET-PG High-Yield Clinical Pearls:** 1. **Chelation Rule:** Tetracyclines and Fluoroquinolones (like Ofloxacin) should not be taken with milk, antacids, or iron preparations due to chelation. 2. **pH Dependency:** Drugs like Ketoconazole, Itraconazole, and Iron salts require low pH; H2 blockers and PPIs significantly reduce their efficacy. 3. **The "Empty Stomach" Rule:** Most macrolides (except Clarithromycin) and Penicillins should be taken on an empty stomach for optimal absorption, but the specific interaction between Azithromycin and antacids is a frequent "trap" question.

Question 259: The maintenance dose of a drug is calculated using which pharmacokinetic parameter?

A. Clearance (Correct Answer)
B. Volume of distribution
C. Oral bioavailability
D. Daily dosage

Explanation: **Explanation:** The goal of a **maintenance dose (MD)** is to maintain a steady-state concentration of a drug in the plasma, ensuring that the rate of drug administration equals the rate of drug elimination. **1. Why Clearance (A) is correct:** Clearance (CL) is the most important pharmacokinetic parameter for determining the maintenance dose. The mathematical relationship is: **Maintenance Dose = (Target Plasma Concentration × Clearance) / Bioavailability** Since clearance represents the volume of plasma cleared of the drug per unit of time, it directly dictates how much drug must be replaced to maintain equilibrium. **2. Why other options are incorrect:** * **Volume of Distribution (Vd):** This parameter is used to calculate the **Loading Dose**, not the maintenance dose. Vd determines how much drug is needed to fill the "reservoir" of the body to reach the target concentration rapidly. * **Oral Bioavailability (F):** While used in the calculation to adjust for the route of administration, it is a fraction that modifies the dose rather than the primary physiological driver of drug replacement. * **Daily Dosage:** This is a clinical instruction (the result of the calculation), not a pharmacokinetic parameter used to derive the dose. **High-Yield Clinical Pearls for NEET-PG:** * **Loading Dose (LD) Formula:** $LD = (Vd \times Cp) / F$ (where $Cp$ is target plasma concentration). * **Maintenance Dose (MD) Formula:** $MD = (CL \times Cp) / F$. * **Steady State:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration, regardless of the dose. * **Rule of Thumb:** If a patient has renal or hepatic impairment, the **Maintenance Dose** must be decreased (due to decreased Clearance), but the **Loading Dose** usually remains the same (unless Vd is altered).

Question 260: Which of the following hormones utilizes the JAK-STAT transducer mechanism?

A. Somatostatin
B. Growth hormone (Correct Answer)
C. Insulin
D. Adenosine

Explanation: The **JAK-STAT (Janus Kinase-Signal Transducer and Activator of Transcription)** pathway is a distinct signaling mechanism used by receptors that lack intrinsic tyrosine kinase activity but associate with soluble tyrosine kinases [4]. **1. Why Growth Hormone (GH) is correct:** Growth hormone belongs to the **Cytokine Receptor Superfamily** [3]. When GH binds to its receptor, it induces dimerization, which activates cytoplasmic **JAK2** kinases [1]. These kinases phosphorylate the receptor and **STAT** proteins. The phosphorylated STATs then translocate to the nucleus to regulate gene transcription [5]. Other hormones using this pathway include Prolactin, Erythropoietin, and Leptin [2]. **2. Why the other options are incorrect:** * **Somatostatin:** Acts via **G-Protein Coupled Receptors (GPCR)**, specifically the $G_i$ subtype, which inhibits adenylyl cyclase and decreases cAMP levels. * **Insulin:** Utilizes a **Receptor Tyrosine Kinase (RTK)**. Unlike GH, the insulin receptor has *intrinsic* enzymatic activity (the receptor itself is a kinase) and primarily signals through the IRS-1/PI3K pathway. * **Adenosine:** Acts through **GPCRs** ($A_1, A_2, A_3$ receptors). $A_1$ is $G_i$-coupled (inhibitory), while $A_2$ is $G_s$-coupled (stimulatory). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for JAK-STAT:** "**PIGGLy**" — **P**rolactin, **I**mmunomodulators (Cytokines/Interferons), **G**rowth Hormone, **G**-CSF, **L**eptin/Erythropoietin. * **Laron Dwarfism:** Caused by a mutation in the Growth Hormone receptor, leading to defective JAK-STAT signaling despite high GH levels. * **Tofacitinib:** A JAK inhibitor used clinically in the treatment of Rheumatoid Arthritis [5].

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free